The DOI matches its Crossref record; 29 of the 30 references it cites were found in a registry or an index.
Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India
Open accessAbstract
econdary infections are known to complicate the clinical course of coronavirus disease .Bacterial infections are the most common secondary infections, but increasing reports of systemic fungal infections are causing concern.In the early part of the COVID-19 pandemic, <1% of secondary infections reported in COVID-19 patients were fungal (1,2).Preexisting conditions, indiscriminate use of antimicrobial and glucocorticoid drugs, and lapses in infection control practices are putative factors contributing to the emergence of systemic fungal infections in severe COVID-19 cases (3).After incidence of candidemia and invasive aspergillosis in COVID-19 patients increased (4,5), awareness of possible fungal co-infections increased among clinicians and microbiologists.One study reported invasive fungal infections in ≈6% of hospitalized COVID-19 patients (6).Occasional reports of COVID-19-associated mucormycosis (CAM) from various centers (7,8) and a series of 18 cases from a city in South India increased our concerns about CAM (9).India has a high burden of mucormycosis among patients with uncontrolled diabetes mellitus, and many severe COVID-19 patients have diabetes (8,10).India also is one of the countries worst affected by the COVID-19 pandemic.Thus, we would expect India to have many CAM cases.We conducted a nationwide multicenter study to evaluate the epidemiology and outcomes of CAM and compare the results with cases of mucormycosis unrelated to COVID-19 (non-CAM).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In India, a steep increase of mucormycosis cases was observed during the COVID-19 pandemic [88,89], driven by specific immunological mechanisms that predispose COVID-19 patients to mucormycosis [87], as well as overuse of systemic corticosteroids and an increase in the population with undiagnosed or uncontrolled diabetes [88].”
From Race and ethnicity: Risk factors for fungal infections? (2023) · cites this paper as [89]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cornely, O. A., Alastruey‐Izquierdo, A., Arenz, D., Chen, S. C. ‐., Dannaoui, É., a, B. H., Hoenigl, M., Jensen, H. E., Lagrou, K., Lewis, R. E., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30312-3 · Cited by 1,843
Self-citationJeong, W., Keighley, C., Wolfe, R. S., Lee, W. L., Slavin, M. A., Kong, D. C. M., & Chen, S. C.-A. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.07.011 · Cited by 1,105
Global Epidemiology of Mucormycosis
Prakash, H., & Chakrabarti, A. (2019) · Journal of Fungi · doi:10.3390/jof5010026 · Cited by 955
Self-citationViral and host factors related to the clinical outcome of COVID-19
Zhang, X., Tan, Y., Ling, Y., Lü, G., Liu, F., Yi, Z., Jia, X., Wu, M., Shi, B., Xu, S., et al. (2020) · Nature · doi:10.1038/s41586-020-2355-0 · Cited by 874
Levin, A. T., Hanage, W. P., Owusu-Boaitey, N., Cochran, K. B., Walsh, S. P., & Meyerowitz-Katz, G. (2020) · European Journal of Epidemiology · doi:10.1007/s10654-020-00698-1 · Cited by 844
Pijls, B. G. C. W., Jolani, S., Atherley, A., Derckx, R. T., Dijkstra, J. I. R., Franssen, G. H. L. M., Hendriks, S., Richters, A., Jellema, A., Zalpuri, S., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-044640 · Cited by 596
Garg, D. K., Muthu, V., Sehgal, I. S., Ramachandran, R., Kaur, H., Bhalla, A., Puri, G. D., Chakrabarti, A., & Agarwal, R. (2021) · Mycopathologia · doi:10.1007/s11046-021-00528-2 · Cited by 589
Self-citationSARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas
Müller, J. A., Groß, R. M., Conzelmann, C., Krüger, J., Merle, U., Steinhart, J., Weil, T., Koepke, L., Bozzo, C. P., Read, C., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00347-1 · Cited by 564
Patel, A. K., Kaur, H., Xess, I., Michael, J. S., Savio, J., Rudramurthy, S. M., Singh, R., Shastri, P. S., Umabala, P., Sardana, R., et al. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.11.021 · Cited by 407
Self-citationA prospective multicenter study on mucormycosis in India: Epidemiology, diagnosis, and treatment
Prakash, H., Ghosh, A. K., Rudramurthy, S. M., Singh, P., Xess, I., Savio, J., Pamidimukkala, U., Jillwin, J., Varma, S. C., Das, A., et al. (2018) · Medical Mycology · doi:10.1093/mmy/myy060 · Cited by 392
Self-citation
Flagged first, then by citations
1 of the 30 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Global incidence and mortality of severe fungal disease
Denning, D. W. (2024) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(23)00692-8 · Cited by 1,640
COVID-19-associated fungal infections
Hoenigl, M., Seidel, D., Sprute, R., Cunha, C., Oliverio, M., Goldman, G. H., Ibrahim, A. S., & Carvalho, A. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01172-2 · Cited by 482
Muthu, V., Rudramurthy, S. M., Chakrabarti, A., & Agarwal, R. (2021) · Mycopathologia · doi:10.1007/s11046-021-00584-8 · Cited by 244
Self-citationRudramurthy, S. M., Hoenigl, M., Meis, J. F. G. M., Cornely, O. A., Muthu, V., Gangneux, J., Perfect, J. R., Chakrabarti, A., & ISHAM, E. A. (2021) · Mycoses · doi:10.1111/myc.13335 · Cited by 214
Self-citationThe WHO fungal priority pathogens list: a crucial reappraisal to review the prioritisation
Casalini, G., Giacomelli, A., & Antinori, S. (2024) · The Lancet Microbe · doi:10.1016/s2666-5247(24)00042-9 · Cited by 217
Pathogenesis of Respiratory Viral and Fungal Coinfections
Salazar, F., Bignell, E., Brown, G. D., Cook, P. C., & Warris, A. (2021) · Clinical Microbiology Reviews · doi:10.1128/cmr.00094-21 · Cited by 164
Mucormycosis in 2023: an update on pathogenesis and management
Alqarihi, A., Kontoyiannis, D. P., & Ibrahim, A. S. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1254919 · Cited by 148
COVID-19–associated mucormycosis: a systematic review and meta-analysis of 958 cases
Özbek, L., Topçu, A. U., Manay, M., Esen, B. H., Bektaş, Ş. N., Aydın, S., Özdemir, B., Khostelidi, S. N., Климко, Н. Н., Cornely, O. A., et al. (2023) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2023.03.008 · Cited by 143
Aranjani, J. M., Manuel, A., Razack, H. I. A., & Mathew, S. T. (2021) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0009921 · Cited by 136
Moitra, P., & Madan, J. (2022) · PLoS ONE · doi:10.1371/journal.pone.0264951 · Cited by 102
Muthu, V., Agarwal, R., Patel, A. K., Kathirvel, S., Abraham, O. C., Aggarwal, A. N., Bal, A., Bhalla, A. S., Chhajed, P. N., Chaudhry, D., et al. (2022) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(22)00124-4 · Cited by 95
Self-citationMishra, Y., Prashar, M., Sharma, D. K., Akash, A., Kumar, V. P., & Tilak, T. (2021) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2021.102196 · Cited by 93
Invasive Fungal Infections Complicating COVID-19: A Narrative Review
Casalini, G., Giacomelli, A., Ridolfo, A., Gervasoni, C., & Antinori, S. (2021) · Journal of Fungi · doi:10.3390/jof7110921 · Cited by 95
Coronavirus Disease 2019–Associated Mucormycosis: Risk Factors and Mechanisms of Disease
Narayanan, S., Chua, J. V., & Baddley, J. W. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab726 · Cited by 77
Mucormycosis in COVID-19 pandemic: Risk factors and linkages
Kumar, M., Sarma, D. K., Shubham, S., Kumawat, M., Verma, V., Singh, B., Nagpal, R., & Tiwari, R. (2021) · Current Research in Microbial Sciences · doi:10.1016/j.crmicr.2021.100057 · Cited by 76
Global Cutaneous Mucormycosis: A Systematic Review
Skiada, A., Drogari‐Apiranthitou, M., Pavleas, I., Daikou, E., & Petrikkos, G. L. (2022) · Journal of Fungi · doi:10.3390/jof8020194 · Cited by 76
Hussain, S., Riad, A., Singh, A., Klugarová, J., Antony, B., Banna, H., & Klugar, M. (2021) · Journal of Fungi · doi:10.3390/jof7110985 · Cited by 74
Arora, U., Priyadarshi, M., Katiyar, V., Soneja, M., Garg, P., Gupta, I., Bharadiya, V. M., Berry, P., Ghosh, T., Patel, L., et al. (2021) · Journal of Infection · doi:10.1016/j.jinf.2021.12.039 · Cited by 74
Self-citationCurrent treatments against mucormycosis and future directions
Smith, C., & Lee, S. C. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010858 · Cited by 74
Iron and iron-related proteins in COVID-19
Suriawinata, E., & Mehta, K. J. (2022) · Clinical and Experimental Medicine · doi:10.1007/s10238-022-00851-y · Cited by 69
Risk factors associated with the mucormycosis epidemic during the COVID-19 pandemic
Bhanuprasad, K., Abi Manesh, S., Devasagayam, E., Varghese, L., Cherian, L. M., Kurien, R., Rajiv Karthik, K., Deodhar, D., Vanjare, H. A., Peter, J., et al. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.08.037 · Cited by 65
Multicenter Case–Control Study of COVID-19–Associated Mucormycosis Outbreak, India
Muthu, V., Agarwal, R., Rudramurthy, S. M., Thangaraju, D., Shevkani, M. R., Patel, A. K., Shastri, P. S., Tayade, A., Bhandari, S., Gella, V., et al. (2023) · Emerging infectious diseases · doi:10.3201/eid2901.220926 · Cited by 65
Self-citationMorris, A. C., Kohler, K., Corte, T. D., Ercole, A., de Grooth, H., Elbers, P., Póvoa, P. M. S. R., Morais, R., Koulenti, D., Jog, S., et al. (2022) · Critical Care · doi:10.1186/s13054-022-04108-8 · Cited by 61
Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach
Azhar, A., Khan, W. H., Khan, P. A., Alhosaini, K. A., Owais, M., & Ahmad, A. (2022) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2022.02.007 · Cited by 60
What Is New in Pulmonary Mucormycosis?
Danion, F., Coste, A., Hyaric, C. L., Melenotte, C., Lamoth, F., Calandra, T., Garcia‐Hermoso, D., Aimanianda, V., Lanternier, F., & Lortholary, O. (2023) · Journal of Fungi · doi:10.3390/jof9030307 · Cited by 58
Race and ethnicity: Risk factors for fungal infections?
Jenks, J. D., Aneke, C. I., Al-Obaidi, M. M., Egger, M., Garcia, L., Gaines, T., Hoenigl, M., & Thompson, G. R. (2023) · PLOS Pathogens · doi:10.1371/journal.ppat.1011025 · Cited by 55
Ramaswami, A., Sahu, A. K., Kumar, A., Suresh, S., Nair, A., Gupta, D. K., Chouhan, R., Bhat, R., Mathew, R., Majeed, J. A., et al. (2021) · QJM · doi:10.1093/qjmed/hcab190 · Cited by 55
Self-citationSeidel, D., Simon, M., Sprute, R., Lubnow, M., Evert, K., Speer, C., Seeßle, J., Khatamzas, E., Merle, U., Behrens, C., et al. (2021) · Mycoses · doi:10.1111/myc.13379 · Cited by 54
Rizk, N., Moghnieh, R., Haddad, N., Rebeiz, M., Zeenny, R. M., Hindy, J.-R., Orlando, G., & Kanj, S. S. (2021) · Antibiotics · doi:10.3390/antibiotics10111320 · Cited by 54
Neoh, C. F., Chen, S. C. ‐., Lanternier, F., Tio, S. Y., Halliday, C. L., Kidd, S. E., Kong, D. C. M., Meyer, W., Hoenigl, M., & Slavin, M. A. (2024) · Clinical Microbiology Reviews · doi:10.1128/cmr.00004-23 · Cited by 53
COVID-19–Associated Rhino-Orbital-Cerebral Mucormycosis
Bhattacharyya, A., Sarma, P., Kaur, H., Kumar, S., Bhattacharyya, J., Prajapat, M., Prakash, A., Sharma, S., HariKrishnaReddy, D., Thota, P., et al. (2021) · Indian Journal of Pharmacology · doi:10.4103/ijp.ijp_839_21 · Cited by 52
Connecting the Dots: Interplay of Pathogenic Mechanisms between COVID-19 Disease and Mucormycosis
Prakash, H., Skiada, A., Paul, R. A., Chakrabarti, A., & Rudramurthy, S. M. (2021) · Journal of Fungi · doi:10.3390/jof7080616 · Cited by 51
Self-citationSurge of mucormycosis during the COVID-19 pandemic
Dam, P., Cardoso, M. H. E. S., Mandal, S., Franco, O. L., Sağıroğlu, P. Ç., Polat, O. A., Kökoğlu, K., Mondal, R., Mandal, A. K., & Öçsoy, İ. (2023) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2023.102557 · Cited by 53
Gouzien, L., Che, D., Cassaing, S., Lortholary, O., Letscher‐Bru, V., Paccoud, O., Obadia, T., Morio, F., Moniot, M., Cateau, E., et al. (2024) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2024.101010 · Cited by 50
Pokharkar, O., Lakshmanan, H., Zyryanov, G. V., & Tsurkan, M. V. (2022) · Marine Drugs · doi:10.3390/md20030215 · Cited by 50
Dubey, S., Mukherjee, D., Sarkar, P., Mukhopadhyay, P., Barman, D., Bandopadhyay, M., Pandit, A., Sengupta, A., Das, S. K., Ghosh, S., et al. (2021) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2021.102267 · Cited by 47
Pruthi, H., Muthu, V., Bhujade, H., Sharma, A. K., Baloji, A., Ratnakara, R. G., Bal, A., Singh, H., Sandhu, M. S., Negi, S. L., et al. (2021) · Mycopathologia · doi:10.1007/s11046-021-00610-9 · Cited by 47
Self-citationCoronavirus Disease-Associated Mucormycosis from a Tertiary Care Hospital in India: A Case Series
Singh, Y., Ganesh, V., Kumar, S., Patel, N. B., Aggarwala, R., Soni, K. D., & Trikha, A. (2021) · Cureus · doi:10.7759/cureus.16152 · Cited by 46
Mazzitelli, M., Gregori, D., Sasset, L., Trevenzoli, M., Scaglione, V., Menzo, S. L., Marinello, S., Mengato, D., Venturini, F., Tiberio, I., et al. (2023) · Microorganisms · doi:10.3390/microorganisms11040984 · Cited by 46
Watanabe, A., So, M., Mitaka, H., Ishisaka, Y., Takagi, H., Inokuchi, R., Iwagami, M., & Kuno, T. (2022) · Mycopathologia · doi:10.1007/s11046-022-00627-8 · Cited by 44
Huang, S., Wu, A. Y.-J., Lee, S. S., Huang, Y., Lee, C.-Y., Yang, T.-L., Wang, H.-W., Chen, H.-J., Chen, Y. C., Ho, T., et al. (2022) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2022.12.004 · Cited by 44
Chavda, V. P., & Apostolopoulos, V. (2021) · Maturitas · doi:10.1016/j.maturitas.2021.07.009 · Cited by 43
Muthu, V., Mohan Kumar, H., Paul, R. A., Zohmangaihi, D., Choudhary, H., Rudramurthy, S. M., Panda, N. K., Pannu, A. K., Sharma, N., Sharma, S., et al. (2021) · Mycoses · doi:10.1111/myc.13365 · Cited by 43
Self-citationBiswal, M., Gupta, P., Kanaujia, R., Kaur, K., Kaur, H., Vyas, A., Hallur, V., Behera, B., Padaki, P. A., Savio, J., et al. (2022) · Journal of Hospital Infection · doi:10.1016/j.jhin.2022.01.016 · Cited by 43
Self-citationCT Findings of COVID-19–associated Pulmonary Mucormycosis: A Case Series and Literature Review
Garg, M. K., Prabhakar, N., Muthu, V., Farook, S., Kaur, H., Suri, V., & Agarwal, R. (2021) · Radiology · doi:10.1148/radiol.2021211583 · Cited by 42
Self-citationCOVID-19 associated mucormycosis – An emerging threat
Chao, C., Lai, C., & Yu, W. (2022) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2021.12.007 · Cited by 40
Laboratory diagnosis of mucormycosis
Gupta, M. K., Kumar, N., Dhameja, N., Sharma, A., & Tilak, R. (2022) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_1479_21 · Cited by 40
Pathogenesis and Pathology of COVID-Associated Mucormycosis: What Is New and Why
Radotra, B., & Challa, S. (2022) · Current Fungal Infection Reports · doi:10.1007/s12281-022-00443-z · Cited by 40
Coronavirus Disease 2019-Associated Mucormycosis in France: A Rare but Deadly Complication
Danion, F., Letscher‐Bru, V., Guitard, J., Sitbon, K., Dellière, S., Angoulvant, A., Désoubeaux, G., Botterel, F., Bellanger, A., Gargala, G., et al. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab566 · Cited by 39
COVID-19-associated mucormycosis in India: Why such an outbreak?
Pasquier, G. (2023) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2023.101393 · Cited by 38
Serum iron indices in COVID‐19‐associated mucormycosis: A case–control study
Mohan Kumar, H., Sharma, P., Rudramurthy, S. M., Sehgal, I. S., Prasad, K. T., Pannu, A. K., Das, R., Panda, N. K., Sharma, N., Chakrabarti, A., et al. (2021) · Mycoses · doi:10.1111/myc.13391 · Cited by 36
Self-citationCOVID-19 and Fungal infections: a double debacle
Mina, S., Yaakoub, H., Annweiler, C., Dubée, V., & Papon, N. (2022) · Microbes and Infection · doi:10.1016/j.micinf.2022.105039 · Cited by 35
Diwakar, J., Samaddar, A., Konar, S. K., Bhat, M. D., Manuel, E., Veenakumari, H. B., Nandeesh, B. N., Parveen, A., Hajira, S. N., Srinivas, D., et al. (2021) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2021.101203 · Cited by 34
Oral Fungal Infections: Past, Present, and Future
Cannon, R. D. (2022) · Frontiers in Oral Health · doi:10.3389/froh.2022.838639 · Cited by 34
Madhavan, Y., Sai, K. V., Shanmugam, D. K., Aashabharathi, M., Devi, G. K., Mohanta, Y. K., Venugopal, D. C., Mohanta, T. K., Sharma, N., & Saravanan, M. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11133620 · Cited by 36
The Impact of Coronavirus Disease 2019 on Viral, Bacterial, and Fungal Respiratory Infections
Losier, A., Gupta, G., Caldararo, M. D., & Cruz, C. S. D. (2023) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2022.11.018 · Cited by 35
Davies, G. E., & Thornton, C. R. (2022) · Journal of Fungi · doi:10.3390/jof8070756 · Cited by 32
Epidemiology, Modern Diagnostics, and the Management of Mucorales Infections
Pham, D., Howard‐Jones, A. R., Sparks, R., Stefani, M., Sivalingam, V., Halliday, C. L., Beardsley, J., & Chen, S. C. ‐. (2023) · Journal of Fungi · doi:10.3390/jof9060659 · Cited by 32
Recent Developments in the Diagnosis of Mucormycosis
Dannaoui, É. (2022) · Journal of Fungi · doi:10.3390/jof8050457 · Cited by 31
Isolated tracheobronchial mucormycosis: Report of a case and systematic review of literature
Damaraju, V., Agarwal, R., Dhooria, S., Sehgal, I. S., Prasad, K. T., Gupta, K., Prabhakar, N., Aggarwal, A. N., & Muthu, V. (2022) · Mycoses · doi:10.1111/myc.13519 · Cited by 31
Self-citationMuthu, V., Agarwal, R., Rudramurthy, S. M., Thangaraju, D., Shevkani, M. R., Patel, A. K., Shastri, P. S., Tayade, A., Bhandari, S., Gella, V., et al. (2023) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2023.12.006 · Cited by 30
Self-citationMucormycosis: A triple burden in patients with diabetes during COVID-19 Pandemic
Fathima, A. S., Mounika, V. L., Kumar, V. U., Gupta, A. K., Garapati, P., Ravichandiran, V., Dhingra, S., & Murti, K. (2021) · Health Sciences Review · doi:10.1016/j.hsr.2021.100005 · Cited by 30
COVID-19 and Plethora of Fungal Infections
Kundu, R., & Singla, N. (2022) · Current Fungal Infection Reports · doi:10.1007/s12281-022-00432-2 · Cited by 31
Mucormycosis, Past and Present: A Comprehensive Review
Gupta, I., Baranwal, P., Singh, G., & Gupta, V. (2023) · Future Microbiology · doi:10.2217/fmb-2022-0141 · Cited by 30
Mucormycosis and COVID-19-Associated Mucormycosis: Insights of a Deadly but Neglected Mycosis
García-Carnero, L. C., & Mora-Montes, H. M. (2022) · Journal of Fungi · doi:10.3390/jof8050445 · Cited by 29
Pfaller, M. A., Carvalhaes, C. G., DeVries, S. D., Rhomberg, P. R., & Castanheira, M. (2022) · Medical Mycology · doi:10.1093/mmy/myac028 · Cited by 30
Mucormycosis in the COVID-19 Environment: A Multifaceted Complication
Sharma, R., Kumar, P., Rauf, A., Chaudhary, A., Prajapati, P., Emran, T. B., Lima, C. M. G., & Conte‐Júnior, C. A. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.937481 · Cited by 29
Self-citationSahu, M., Shah, M., Mallela, V. R., Kola, V. R., Boorugu, H. K., Punjani, A., Kumar, R. V., Kumar, S. C. R., Manusrut, M., Kumar, S. C. R., et al. (2022) · Infection · doi:10.1007/s15010-022-01891-y · Cited by 29
Combination therapy in Mucormycosis: Current evidence from the world literature, a mini review
Meena, D. S., Kumar, D., & Bohra, G. K. (2022) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2022.101332 · Cited by 29
Mucormycosis and COVID-19 an epidemic in a pandemic?
Banerjee, I., Robinson, J., Asim, M., Sathian, B., & Banerjee, I. (2021) · Nepal Journal of Epidemiology · doi:10.3126/nje.v11i2.37342 · Cited by 27
Sanghvi, D., & Kale, H. A. (2021) · Clinical Radiology · doi:10.1016/j.crad.2021.07.004 · Cited by 27
Dravid, A. N., Kashiva, R., Khan, Z. A., Bande, B. D., Memon, D., Kodre, A., Potdar, P., Mane, M., Tamboli, A., Pawar, V., et al. (2022) · Mycoses · doi:10.1111/myc.13435 · Cited by 27
Chakrabarti, A., Patel, A. K., Soman, R. N., & Todi, S. K. (2023) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2023.2257895 · Cited by 26
Self-citationCOVID-19 associated mucormycosis: evolving technologies for early and rapid diagnosis
Samson, R., & Dharne, M. S. (2021) · 3 Biotech · doi:10.1007/s13205-021-03080-4 · Cited by 26
COVID-19 associated mucormycosis: A Descriptive Multisite Study from India
Gupta, R., Kesavadev, J., Krishnan, G., Agarwal, S., Saboo, B., Shah, M., Mittal, A., Durani, S., Luthra, A., Singhal, A., et al. (2021) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2021.102322 · Cited by 25
COVID-19-Associated Pulmonary Mucormycosis
Krishna, V., Bansal, N., Morjaria, J. B., & Kaul, S. (2022) · Journal of Fungi · doi:10.3390/jof8070711 · Cited by 25
Ponnaiah, M., Ganesan, S., Bhatnagar, T., Thulasingam, M., Majella, M. G., Karuppiah, M., Abdulkader, R. S., Alexander, A., Sarkar, S., Kar, S. S., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0272042 · Cited by 25
Self-citationCzech, M. M., & Cuellar‐Rodríguez, J. (2024) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2024.11.008 · Cited by 24
Ghosh, A. K., Singh, R., Reddy, S., Singh, S., Rudramurthy, S. M., Kaur, H., Choudhary, H., & Chakrabarti, A. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.953750 · Cited by 24
Self-citationUpdated estimation of the burden of fungal disease in Vietnam
Duong, T. N., Le, M., Beardsley, J., Denning, D. W., Ngoc, H. L., & Nguyen, B. T. (2022) · Mycoses · doi:10.1111/myc.13559 · Cited by 24
Wu, H.-Y., Chang, P.-H., Huang, Y., Tsai, C.-S., Chen, K., Lin, I., Hsih, W.-H., Tsai, W.-L., Chen, J.-A., Yang, T.-L., et al. (2022) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2022.12.003 · Cited by 24
Clinical care for severe acute respiratory infection: toolkit: COVID-19 adaptation
Paraguassu, É. C., & Lacerda, J. D. P. (2022) · Brazilian Journal of Implantology and Health Sciences · doi:10.36557/2674-8169.2022v4n3p48-330 · Cited by 24
Morrissey, C. O., Kim, H. Y., Garnham, K., Dao, A., Chakrabarti, A., Perfect, J. R., Alastruey‐Izquierdo, A., Harrison, T. S., Bongomin, F., Galas, M., et al. (2024) · Medical Mycology · doi:10.1093/mmy/myad130 · Cited by 23
Self-citationCOVID-19-associated rhino-orbital mucormycosis: a single-centre experience of 10 cases
Arjun, R., Félix, V., Niyas, V. K. M., Kumar, M. A. S., Krishnan, R. B., Mohan, V., Ansar, A., Gautaam, S., & Lalitha, S. (2021) · QJM · doi:10.1093/qjmed/hcab176 · Cited by 23
Covid-19 and mucormycosis (Black Fungus): An epidemic within the pandemic
Gambhir, R. S., Aggarwal, A., Bhardwaj, A., Kaur, A., Sohi, R. K., & Mehta, S. (2021) · Roczniki Państwowego Zakładu Higieny · doi:10.32394/rpzh.2021.0169 · Cited by 22
Asdaq, S. M. B., Rajan, A., Damodaran, A., Kamath, S. R., Nair, K. S., Zachariah, S. M., Sahu, R. K., Fattepur, S., Sreeharsha, N., Nair, A. B., et al. (2021) · Antibiotics · doi:10.3390/antibiotics10111308 · Cited by 22
Patel, A. K., Patel, K. K., Patel, K., Shah, K., & Chakrabarti, A. (2021) · Mycoses · doi:10.1111/myc.13420 · Cited by 22
Self-citationMucormycosis: The hidden and forgotten disease
Darwish, R. M., Almasri, M., & Almasri, M. (2022) · Journal of Applied Microbiology · doi:10.1111/jam.15487 · Cited by 22
Palou, E. Y., Ramos, M. A., Cherenfant, E., Duarte, A., Fuentes-Barahona, I. C., Zambrano, L. I., Muñoz‐Lara, F., Montoya-Ramirez, S. A., Cardona-Ortiz, A. F., Valle-Reconco, J. A., et al. (2021) · Vaccines · doi:10.3390/vaccines9080826 · Cited by 25
Study of Profile of Mucormycosis During the Second Wave of COVID-19 in a Tertiary Care Hospital
Kamath, S. G., Kumar, M., Sarkar, N., Ahmed, T., & Sunder, A. (2022) · Cureus · doi:10.7759/cureus.21054 · Cited by 21
Epidemiology of COVID-19–Associated Mucormycosis
Tayabali, K., Pothiwalla, H., & Narayanan, S. (2023) · Current Fungal Infection Reports · doi:10.1007/s12281-023-00464-2 · Cited by 21
Rhizopus homothallicus: An emerging pathogen in era of COVID-19 associated mucormycosis
Kaur, H., Kanaujia, R., & Rudramurthy, S. M. (2021) · Indian Journal of Medical Microbiology · doi:10.1016/j.ijmmb.2021.06.013 · Cited by 21
Self-citationImaging of Pulmonary Superinfections and Co-Infections in COVID-19
Naranje, P., Bhalla, A. S., Jana, M., Garg, M. K., Nair, A. D., Singh, S. K., & Banday, I. A. (2021) · Current Problems in Diagnostic Radiology · doi:10.1067/j.cpradiol.2021.09.009 · Cited by 20
Notes from the Field: COVID-19–Associated Mucormycosis — Arkansas, July–September 2021
Dulski, T. M., DeLong, M., Garner, K., Patil, N., Cima, M. J., Rothfeldt, L., Gulley, T., Porter, A., Vyas, K. S., Liverett, H. K., et al. (2021) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7050a3 · Cited by 20
Pfaller, M. A., Carvalhaes, C. G., & Castanheira, M. (2023) · Mycoses · doi:10.1111/myc.13620 · Cited by 20
Soman, R. N., Chakraborty, S., & Joe, G. (2022) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2022.04.009 · Cited by 20
The recent mucormycosis storm over Indian sky
Chakrabarti, A. (2021) · Indian Journal of Medical Microbiology · doi:10.1016/j.ijmmb.2021.06.010 · Cited by 20
Self-citationCOVID-19-associated mucormycosis of head-and-neck region: A systematic review
Kamat, M. S., Datar, U. V., Byakodi, S. S., Kamat, S. B., & Kumar, V. V. (2022) · Journal of Clinical and Translational Research · doi:10.18053/jctres.08.202201.003 · Cited by 19
Mucormycosis in COVID-19 pandemic: study at tertiary hospital in India
Chavan, R. P., Ingole, S. M., Nazir, H. A., Desai, W. V., & Kanchewad, G. S. (2022) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-022-07282-1 · Cited by 19
Abi Manesh, S., Devasagayam, E., Bhanuprasad, K., Varghese, L., Kurien, R., Cherian, L. M., Dayanand, D., George, M. M., Kumar, S. S., Rajiv Karthik, K., et al. (2023) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2023.06.017 · Cited by 19
Metadata
- Authors
- Patel, A., Agarwal, R., Rudramurthy, S. M., Shevkani, M., Xess, I., Sharma, R., Savio, J., Sethuraman, N., Madan, S., Shastri, P., Thangaraju, D., Marak, R., Tadepalli, K., Savaj, P., Sunavala, A., Gupta, N., Singhal, T., Muthu, V., Chakrabarti, A., & Network3, M.
- Affiliations
- Sterling Hospitals (IN)
- Medanta The Medicity (IN)
- Corresponding author
- Chakrabarti, Arunaloke
- ORCID
- Venue
- Emerging Infectious Diseases
- Published
- 2021-09
- Volume
- 27
- Issue
- 9
- Pages
- 2349-2359
- ISSN
- 1080-6040 (ISSN-L)
- 1080-6059
- PMC
- PMC8386807
- OpenAlex
- W3164172839
- Cited by
- 479
- References
- 30
- Citations by year
- 2026: 26 · 2025: 35 · 2024: 60 · 2023: 114 · 2022: 163 · 2021: 81
- FWCI
- 33.10
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by
- Locations
- Emerging infectious diseases (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Mycology
- Keywords
- COVID-19-associated mucormycosis, mucormycosis, SARS-CoV-2, secondary fungal infection, invasive fungal infections, clinical outcomes, diabetes mellitus, glucocorticoid use
- MeSH terms
- COVID-19, SARS-CoV-2, Antifungal Agents, Humans, India, Mucormycosis, Retrospective Studies, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
